Form 4: Upstream Bio General Counsel Acquires 100,000 Stock Options

Upstream Bio's General Counsel, Allison Ambrose, was granted 100,000 stock options on December 16, 2024.

Summary

• Allison Ambrose, the General Counsel of Upstream Bio, Inc., was granted 100,000 stock options on December 16, 2024.
• The exercise price of these options is $19.01 per share.
• 25% of the options will vest on December 16, 2025, with the remaining options vesting in 36 equal monthly installments thereafter.
• The vesting is contingent upon Ms. Ambrose's continued service with the company.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management's interests with shareholders. There are no indications of negative sentiment.

Positives

• The granting of stock options to the General Counsel aligns her interests with the company's long-term success.
• The vesting schedule encourages continued service and commitment from the General Counsel.

Risks

• The value of the stock options is dependent on the future performance of Upstream Bio's stock price.
• If Ms. Ambrose leaves the company before the options fully vest, she may forfeit some or all of the options.

Future Outlook

The vesting schedule of the stock options is designed to incentivize the General Counsel's continued service and contribution to the company's growth.

Industry Context

Stock option grants are a common practice in the biotechnology industry to attract and retain key talent, aligning their interests with the company's performance.

Comparison to Industry Standards

• Stock option grants are a standard form of compensation for executives in the biotech industry, similar to companies like Moderna, BioNTech, and Regeneron.
• The vesting schedule of 25% after one year and the remainder over three years is a typical vesting schedule for stock options in the industry.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes the General Counsel to contribute to the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership team.

Key Dates

Keywords

stock options, Upstream Bio, insider trading, executive compensation, vesting, equity